These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16325808)

  • 1. Effects of a phosphodiesterase 3 inhibitor, olprinone, on rhythmical change in tension of human gastroepiploic artery.
    Adachi H; Kakiki M; Kishi Y
    Eur J Pharmacol; 2005 Dec; 528(1-3):137-43. PubMed ID: 16325808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential pharmacologic sensitivities of phosphodiesterase-3 inhibitors among human isolated gastroepiploic, internal mammary, and radial arteries.
    Onomoto M; Tsuneyoshi I; Yonetani A; Suehiro S; Matsumoto K; Sakata R; Kanmura Y
    Anesth Analg; 2005 Oct; 101(4):950-956. PubMed ID: 16192501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cyclic GMP-inhibited phosphodiesterases 3A and 3B (PDE3A and PDE3B) in rat tissues: differential subcellular localization and regulated expression by cyclic AMP.
    Liu H; Maurice DH
    Br J Pharmacol; 1998 Dec; 125(7):1501-10. PubMed ID: 9884079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible mechanisms underlying the vasodilatation induced by olprinone, a phosphodiesterase III inhibitor, in rabbit coronary artery.
    Ohashi M; Dohi Y; Itoh T
    Br J Pharmacol; 2000 Mar; 129(5):1000-6. PubMed ID: 10696101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of phosphodiesterase III inhibitors on human neutrophil function.
    Mikawa K; Akamatsu H; Nishina K; Shiga M; Maekawa N; Obara H; Niwa Y
    Crit Care Med; 2000 Apr; 28(4):1001-5. PubMed ID: 10809273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the low Km cyclic AMP phosphodiesterase and activation of the cyclic AMP system in vascular smooth muscle by milrinone.
    Silver PJ; Lepore RE; O'Connor B; Lemp BM; Hamel LT; Bentley RG; Harris AL
    J Pharmacol Exp Ther; 1988 Oct; 247(1):34-42. PubMed ID: 2845058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of cyclic nucleotide phosphodiesterase 3A in isolated rat submandibular acini.
    Shimizu K; Murata T; Hiramoto K; Sugiyama T; Nakagawa T; Manganiello VC; Tagawa T
    Arch Oral Biol; 2006 Feb; 51(2):83-8. PubMed ID: 16102722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasorelaxant effect of phosphodiesterase-inhibitor milrinone in the human radial artery used as coronary bypass graft.
    He GW; Yang CQ
    J Thorac Cardiovasc Surg; 2000 May; 119(5):1039-45. PubMed ID: 10788827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasorelaxant effect of olprinone, an inhibitor of phosphodiesterase 3, on mesenteric small artery and vein of rabbits.
    Fujimoto S; Ohashi M; Hiramoto A; Inoue Y; Nagai K; Shiokawa H; Itoh T
    Eur J Pharmacol; 1998 Jul; 353(2-3):239-46. PubMed ID: 9726653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New insight into the role of phosphodiesterase 3A in porcine oocyte maturation.
    Sasseville M; Côté N; Guillemette C; Richard FJ
    BMC Dev Biol; 2006 Oct; 6():47. PubMed ID: 17038172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different effects of olprinone on contractility in nonfatigued and fatigued diaphragm in dogs.
    Fujii Y; Toyooka H
    Can J Anaesth; 2000 Dec; 47(12):1243-8. PubMed ID: 11132748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasorelaxant effects of SCA40 (a phosphodiesterase III inhibitor) in pulmonary vascular preparations in rats.
    Crilley TK; Wanstall JC; Bonnet PA
    Clin Exp Pharmacol Physiol; 1998 May; 25(5):355-60. PubMed ID: 9612663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasorelaxant effect of a phosphodiesterase 3 inhibitor, olprinone, on isolated human radial artery.
    Adachi H; Kamata S; Kodama K; Nagakura T
    Eur J Pharmacol; 2000 May; 396(1):43-7. PubMed ID: 10822053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of phosphodiesterase III inhibitor (Olprinone) on thoracic duct lymph flow in anesthetized sheep with experimentally induced heart failure by endothelin-1.
    Tomoyasu M; Onizuka M; Inagaki M; Sato Y; Yamamoto T; Ishikawa S; Mitsui T
    Lymphology; 2002 Dec; 35(4):144-52. PubMed ID: 12570323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential vasodilation response to olprinone in rabbit renal and common carotid arteries.
    Minonishi T; Ogawa K; Tokinaga Y; Negoro T; Kimoto Y; Hatano Y
    J Anesth; 2010 Feb; 24(1):61-6. PubMed ID: 20175287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Differences in hemodynamic effects of amrinone, milrinone and olprinon after cardiopulmonary bypass in valvular cardiac surgery].
    Sha K; Shimokawa M; Ishimaru K; Kawaraguchi Y; Takahashi M; Yanaidani F; Kitaguchi K; Furuya H
    Masui; 2000 Sep; 49(9):981-6. PubMed ID: 11025952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of dopamine and olprinone on ventricular energetics in sevoflurane-induced acute left ventricular depression in dogs.
    Iwade M; Nomura M; Uezono S; Ashikari E; Ozaki M
    J Cardiothorac Vasc Anesth; 2006 Jun; 20(3):358-63. PubMed ID: 16750736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of amrinone on renal blood flow and cardiac function, in comparison with those of milrinone and olprinone, in anesthetized dog].
    Fujishima K; Yamamoto A; Hachisu M
    Nihon Yakurigaku Zasshi; 1998 Dec; 112(6):371-80. PubMed ID: 10202762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of amrinone, milrinone and olprinone in reversing bupivacaine-induced cardiovascular depression.
    Hirabayashi Y; Igarashi T; Saitoh K; Fukuda H; Suzuki H; Shimizu R
    Acta Anaesthesiol Scand; 2000 Oct; 44(9):1128-33. PubMed ID: 11028735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repetitive preischemic infusion of phosphodiesterase III inhibitor olprinone elicits cardioprotective effects in the failing heart after myocardial infarction.
    Nomura Y; Horimoto H; Mieno S; Nakahara K; Okawa H; Yoshida M; Shinjiro S
    Mol Cell Biochem; 2003 Jun; 248(1-2):179-84. PubMed ID: 12870671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.